Immunotherapy Combination Elicit Waves of Response in Advanced Melanoma
Source: CureToday, September 2024
A new algorithm has found that combining immune checkpoint inhibitors bolsters immune response among some patients with advanced melanoma.
Cyclone, an algorithm developed to track immune responses and patterns over time among patients with cancer by tracking receptors of individual T cells, has found that new immune cells are enlisted to fight advanced melanoma with every infusion of a pair of checkpoint inhibitor therapies, researchers have announced.
Cyclone was developed by researchers at the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center, who published their findings in Cancer Cell, according to a news release from the University of Pennsylvania.